8
Participants
Start Date
June 30, 2003
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
cisplatin
60 mg/m2 IV day 1, every 21 days for 4 cycles.
cyclophosphamide
25 mg by mouth BID days 8-19 or each cycle x 4 cycles. After restaging (if no progression) maintenance cyclophosphamide alone 25 mg by mouth BID daily until disease progression
etoposide
120 mg/m2 IV days 1-3 OR 120 mg/m2 IV day 1 and 120 mg/m2 by mouth BID days 2-3
Gundersen Lutheran Center for Cancer and Blood, La Crosse
Gundersen Lutheran Health System
OTHER